Publikationstyp: | Patent |
Titel: | Composition for treatment of pathogens that are resistant to tetracyclines |
Erfinder/-in: | Schneider, Peter Riedl, Rainer Tigges, Marcel Gitzinger, Marc Pieren, Michel Levi, Assaf Sephton, Mark Schellhorn, Birgit Züger, Patrik Brand, Michael Gygax, Daniel Spies, Peter |
Patentanmelder/-in: | BioVersys AG |
Anmeldedatum: | 3-Feb-2014 |
Erscheinungsdatum: | 9-Dez-2015 |
Publikationsnummer: | EP2950793 |
metadata.zhaw.publication.code: | A1 |
Veröffentlicht als: | EP2762134A1; EP2950793B1; US2015359791A1; US9682079B2; WO2014118361A1 |
Sprache: | Englisch |
Zusammenfassung: | The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram- positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/21726 https://worldwide.espacenet.com/patent/search?q=pn%3DEP2950793A1 |
Departement: | Life Sciences und Facility Management |
Organisationseinheit: | Institut für Chemie und Biotechnologie (ICBT) |
Enthalten in den Sammlungen: | Patente Life Sciences und Facility Management |
Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.